Tag: OTCQB:PRVCF

April 8, 2019

PreveCeutical Announces Default Judgment Against JCN Capital Corp.

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H)(the "Company" or "PreveCeutical"), announces that it has obtained a default judgement against JCN Capital...
March 25, 2019

PreveCeutical Announces Default Judgment Against Essos Corporate Services Inc. and Detona Capital Corp.

PreveCeutical Medical Inc. (CSE:PREV, OTC:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), announces that it has obtained a default judgement against each...
February 13, 2019

PreveCeutical Announces Appointment of Dr. Makarand Jawadekar as President

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical") is pleased to announce the appointment of Dr. Makarand (Mak)...
February 12, 2019

PreveCeutical Announces Closing of Non-Brokered Private Placement

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H)  (the "Company" or "PreveCeutical") announces the closing of a non-brokered private placement financing (the...
January 29, 2019

PreveCeutical to Explore Partnerships with Pharmaceutical and Biotechnology Companies for the Co-Development of its Sol-Gel System

PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H) (the "Company" or "PreveCeutical"), announces that it plans to commence exploratory discussions with pharmaceutical...
January 14, 2019

PreveCeutical Provides Update on the Dual Gene Therapy Program

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical") is pleased to provide an update on its dual gene therapy...
January 8, 2019

PreveCeutical Provides Update on Research Program for Development of Non-Addictive Analgesics

PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") is pleased to announce that it has recently completed a systematic and comprehensive...